Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,578 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Active, Not Recruiting

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT06131398

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Alliance for Multispecialty Research - Kansas City Merriam, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336

Conditions
Advanced MTAP-null Solid Tumors, Biliary Tract Diseases, Biliary Tract Neoplasms, +29 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • California Research Institute Glendale, California, United States
  • Fomat Medical Research Oxnard, California, United States
  • University of California at SF San Francisco, California, United States
View all 75 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

NCT04704934

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations
  • Instituto Medico Especializado Alexander Fleming Colegiales, Buenos Aires F.D., Argentina
  • IONC Instituto Oncologico de Cordoba - Fundacion Richardet Longo Nueva Cordoba, Córdoba Province, Argentina
  • Exelsus San Miguel de Tucumán, Tucumán Province, Argentina
  • Fundacion Cenit Buenos Aires, Argentina
View all 156 locations
View Trial Details
Active, Not Recruiting

Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

NCT06157216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Qilu Hospital of Shandong Univertisy Jinan, Shandong, China
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
  • Jinan Central Hospital Jinan, Shandong, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Active, Not Recruiting

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

NCT06251973

Conditions
Adenocarcinoma Of Esophagus, Advanced Unresectable Gastric Adenocarcinoma, Digestive System Diseases, +22 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • UC Irvine Cancer Center Orange, California, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • UCSF San Francisco, California, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer

NCT06609759

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Qilu Hospital of Shandong Univertisy Jinan, Shandong, China
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
  • Jinan Central Hospital, Jinan, Shandong, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Active, Not Recruiting

A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.

NCT03504397

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • University of Arizona Phoenix, Arizona, United States
  • The University of Arizona Medical Center Tucson, Arizona, United States
  • CBCC Global Research, Inc. at Comprehensive Blood and Cancer Bakersfield, California, United States
  • City of Hope Nat'l Medical Center Duarte, California, United States
View all 220 locations
View Trial Details

Related conditions